T
Theriva Biologics, Inc. (TOVX)
ASE – Real vaqt narxi. Valyuta: USD
0.32
-0.02 (-5.60%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
ASE – Real vaqt narxi. Valyuta: USD
0.32
-0.02 (-5.60%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Theriva Biologics, Inc., klinik bosqichdagi kompaniya, Qo'shma Shtatlarda yuqori darajada ehtiyoj sezilayotgan sohalarda saraton va unga bog'liq kasalliklarni davolash uchun terapevtik vositalarni ishlab chiqadi. Uning asosiy mahsulot nomzodi, VCN-01 (zabilugene almadenorepvec), klinik bosqichdagi onkolitik inson adenovirusi bo'lib, u oshqozon osti bezi saratoni, bosh va bo'yinning yassi hujayrali karsinomasi, tuxumdon saratoni, kolorektal saraton va retinoblastoma bilan og'rigan bemorlar uchun 1-bosqich klinik sinovlarida va 2-bosqich VIRAGE sinovida. Kompaniya, shuningdek, qattiq o'smalarni davolash uchun VCN-11ni; allogenik gematopoez hujayralari transplantatsiyasi (HCT)da o'tkir ko'chiruvchi-xost kasalligining (aGVHD) oldini olish uchun 1b/2a bosqichli klinik sinovlarda bo'lgan og'zaki kapsula profilaktik terapiyasi SYN-004 (ribaxamase)ni; va ko'plab me'da-ichak va metabolik ko'rsatkichlar uchun ichak ishqoriy fosfataza (IAP) fermentining rekombinant og'zaki shakli bo'lgan SYN-020ni ishlab chiqadi. Bundan tashqari, u karbapenem antibiotiklari bilan davolanayotgan bemorlarda aGVH, clostridioides difficile infektsiyasi va mikrobioma shikastlanishining oldini olish uchun SYN-006 kabi klinik bosqichdagi mahsulotlarni; va og'zaki β-laktam antibiotiklari bilan antibiotik bilan bog'liq diareyaning oldini olish uchun SYN-007ni ishlab chiqadi. Kompaniya SYN-020ni o'z ichiga olgan har qanday mahsulotni tadqiq qilish, ishlab chiqish, ishlab chiqarish va tijoratlashtirish bo'yicha Rasayana Therapeutics, Inc. bilan litsenzion kelishuvga ega, shuningdek, SYN-004ning 1b/2a bosqichli klinik sinovini o'tkazish uchun Vashington universiteti tibbiyot maktabi bilan klinika sinovlari kelishuviga ega. Theriva Biologics, Inc.ning shtab-kvartirasi Rokvill, Merilendda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Ramon Alemany Ph.D. | Senior Vice President of Discovery |
| Dr. Vince Wacher Ph.D. | Head of Product & Corporate Development |
| Mr. Steven A. Shallcross CPA | CEO, CFO, Treasurer, Corporate Secretary & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-05 | 10-Q | tmb-20260331x10q.htm |
| 2026-04-20 | PRE 14A | tm2612245d1_pre14a.htm |
| 2026-04-17 | 8-K | tm2612012d1_8k.htm |
| 2026-04-09 | 8-K | tm2611468d1_8k.htm |
| 2026-03-23 | 8-K | tm269559d1_8k.htm |
| 2026-03-16 | DEF 14A | tm267779-2_def14a.htm |
| 2026-03-12 | 8-K | tm268491d1_8k.htm |
| 2026-03-04 | PRE 14A | tm267779d1_pre14a.htm |
| 2026-02-18 | 8-K | tm266493d1_8k.htm |
| 2026-02-12 | 8-K | tm266134d1_8k.htm |